Healio18h
FDA accepts IND for allogenic CAR T-cell therapy that could bypass lymphodepletion
The FDA has accepted an investigational new drug application for ALLO-329, an allogeneic chimeric antigen receptor T-cell ...
rheumatologyadvisor13h
Sildenafil Shows Potential for Improving Cardiac Outcomes in Systemic Sclerosis
Sildenafil was effective for reducing diastolic dysfunction and altered ejection fraction among patients with SSc.
rheumatologyadvisor13h
Ixekizumab for PsO, PsA, axSpA Linked to Low Cerebro-Cardiovascular Events Rate
Patients with psoriasis, psoriatic arthritis, and axial spondylarthritis using ixekizumab have a low incidence rate of cerebro-cardiovascular events.
Frontiers13h
Exploring Autoantibody Roles in Co-occurring SLE and Sjögren’s Disease
Recent decades have witnessed remarkable strides in the realm of clinical research and treatment for Systemic Lupus Erythematosus (SLE) and Sjögren’s ...
Frontiers17h
Synergies and Surprises - Unravelling the Mutual Influence of Sjögren's and Systemic Lupus Erythematosus
Recent decades have witnessed remarkable strides in the realm of clinical research and treatment for Systemic Lupus Erythematosus (SLE) and Sjögren’s ...